AGT and type 2 diabetes mellitus: Reports from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study in patients with early DN and the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartin (RENAAL) study in patients with advanced DN both found that DR was associated with composite renal endpoints31,32.